KR101461165B1 - Hangover curing agent - Google Patents
Hangover curing agent Download PDFInfo
- Publication number
- KR101461165B1 KR101461165B1 KR1020120040947A KR20120040947A KR101461165B1 KR 101461165 B1 KR101461165 B1 KR 101461165B1 KR 1020120040947 A KR1020120040947 A KR 1020120040947A KR 20120040947 A KR20120040947 A KR 20120040947A KR 101461165 B1 KR101461165 B1 KR 101461165B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- hangover
- weight
- comparative example
- powder
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims description 44
- 239000000284 extract Substances 0.000 claims abstract description 71
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 21
- 241000132536 Cirsium Species 0.000 claims abstract description 20
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 17
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 17
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 17
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- 235000013305 food Nutrition 0.000 claims description 29
- 244000010000 Hovenia dulcis Species 0.000 claims description 11
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 11
- 230000035622 drinking Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 6
- 241000195955 Equisetum hyemale Species 0.000 claims description 4
- 229940112822 chewing gum Drugs 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 4
- 241000242583 Scyphozoa Species 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 238000004519 manufacturing process Methods 0.000 description 20
- 230000000694 effects Effects 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 9
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 9
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 9
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000007848 Alcoholism Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 201000007930 alcohol dependence Diseases 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 241001070941 Castanea Species 0.000 description 3
- 235000014036 Castanea Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000013717 Houttuynia Nutrition 0.000 description 3
- 240000000691 Houttuynia cordata Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229940087559 grape seed Drugs 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 235000008586 Hovenia Nutrition 0.000 description 2
- 241000405398 Hovenia Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000007602 hot air drying Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 244000209117 Castanea crenata Species 0.000 description 1
- 235000003801 Castanea crenata Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 241000729173 Cirsium japonicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241000282821 Hippopotamus Species 0.000 description 1
- 241000414067 Inonotus obliquus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000015090 marinades Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물, 율피 분말 및 헛개나무 열매 추출물을 포함하는 조성물에 관한 것으로, 포도씨 추출물 42~48중량%, 차가버섯 추출물 23~27중량%, 엉겅퀴 추출물 12~17중량%, 율피 분말 3~8중량% 및 헛개나무 열매 추출물 2~6중량%로 조성되어 숙취해소에 우수한 효과를 발휘한다.The present invention relates to a composition comprising a grape seed extract, a chaga mushroom extract, a thistle extract, a juli powder and a hornbug extract, wherein the grape seed extract is 42 to 48 wt%, the chaga mushroom extract is 23 to 27 wt%, the thistle extract is 12 to 17 3 to 8% by weight of the jellyfish powder, and 2 to 6% by weight of the hornberry fruit extract.
Description
본 발명은 숙취해소용 식품조성물에 관한 것으로, 구체적으로는 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물, 율피 분말 및 헛개나무 열매 추출물을 포함하여 숙취해소에 우수한 효과를 나타내는 조성물에 관한 것이다.
The present invention relates to a food composition useful for hangover, and more particularly, to a composition containing grape seed extract, chaga mushroom extract, thistle extract, chestnut powder and hornbug fruit extract, showing excellent effects on hangover resolution.
회식과 접대가 잦고, 여러 가지 요인에 의한 스트레스가 많은 현대인들에게 음주는 필수적인 것으로 자리 잡고 있으며, 그로 인하여 음주기회가 상당히 증가하고 있다. Drinking is becoming a necessity for modern people who frequent drinks and entertainments and are stressed by various factors, thereby drastically increasing opportunities for drinking.
한국 보건 사회 연구원 조사에 따르면 우리나라 20세 이상 성인의 경우 음주 빈도가 한 달에 약 8일이며, 남성의 경우 11일, 여성의 경우 약 4일 정도로 나타났고, 이때 만취 횟수는 주 1회 이상이 4.7% 정도, 1개월에 1 내지 3회가 약 13.2%로 나타났는데, 국민 건강의 측면에서 상당히 우려할 만한 수준이다.According to a survey by the Korea Institute of Health and Social Affairs, the frequency of drinking in Korea over 20 years old was about 8 days per month, 11 days for men and about 4 days for women. 4.7%, about 1 ~ 3 times a month, about 13.2%, which is very worrisome in terms of public health.
이와 같이 현대인들은 소화할 수 없을 정도의 알코올을 과량 섭취하는데, 이로 인한 부작용인 갈증, 전신권태, 피로감, 기억상실, 복부팽만감, 구토, 설사 등의 숙취 현상으로 고생하는 경우가 많으며, 알코올 중독에 걸릴 위험성도 증가하고 있는 실정이다.In this way, modern people eat excessive amounts of alcohol that can not be digested, and they often suffer from side effects such as thirst, general boredom, fatigue, memory loss, abdominal bloating, vomiting and diarrhea. The risk of taking is also increasing.
숙취는 술을 많이 마신 후 나타나는 두통이나 속쓰림 등의 현상을 말하며, 이는, 알코올의 체내 대사과정 중 분해되는 아세트알데하이드가 인체에 유해하게 작용함으로써 나타난다. 알코올은 간에서 알코올 탈수소효소(alcohol dehydrogenase; ADH)에 의해 아세트알데하이드로 산화되고, 다시 알데하이드 탈수소효소(aldehyde dehydrogenase; ALDH)에 의해 아세트산과 수소로 분해된 뒤 소변을 통해 배설된다.Hangover refers to a phenomenon of headache or heartburn after drinking a lot of alcohol, which is caused by the fact that acetaldehyde, which decomposes in the body's metabolism of alcohol, is harmful to the human body. Alcohol is oxidized to acetaldehyde by alcohol dehydrogenase (ADH) in the liver and then decomposed into acetic acid and hydrogen by aldehyde dehydrogenase (ALDH) and excreted through the urine.
한편, 포도씨는 포도 중량의 약 3~5%를 차지하며 지방 9~12%, 단백질 8~12% 및 헤미셀룰로스(hemicellulose)와 같은 식이성섬유소 약 45%를 다량 함유하고 있을 뿐만 아니라 칼슘(Ca), 마그네슘(Mg) 및 인(P)과 같은 무기질의 함량이 높다. 또한, 포도씨는 식물성스테롤, 토코페놀 뿐만 아니라 항암, 항고혈압, 및 항산화성 카테킨화합물을 다량 함유하고 있어 현재 포도씨유 및 추출물은 여러 나라에서 기능성식품, 화장품 및 의약품의 소재로써 널리 사용되고 있다.On the other hand, grape seeds account for about 3 ~ 5% of the grape weight and contain not only a large amount of fat, 9 ~ 12%, protein 8 ~ 12% and 45% of dietary fiber such as hemicellulose, ), Magnesium (Mg), and phosphorus (P). In addition, grape seeds contain a large amount of anticancer, antihypertensive, and antioxidant catechin compounds as well as plant sterols and tocopherols, and grape seed oils and extracts are widely used as functional foods, cosmetics and pharmaceuticals in various countries.
한편, 차가버섯(Inonotus obliquus)은 자작나무 수액을 영양공급원으로 성장하는 버섯의 일종으로, 인체 내에 활성산소를 제거시키는 효소(Superoxide Dismutase)의 역할을 수행하는 베타글루칸(β glucan)이 일반 버섯의 수 백배 포함되어 인체에 활성산소를 제거하는 효소를 공급시키고, 면역력 강화성분을 포함하며, 혈액 속의 지방 수치와 당 수치 콜레스테롤 수치를 감소시키고, 면역력을 강화시켜 성인병을 예방하고, 발생 된 성인병으로 인해 형성되는 활성산소를 제거하여 체내 산도 저하와 혈류청결작용으로 알칼리화하여 연약한 세포를 강화시켜 인체의 치유력을 증대한다.On the other hand, Inonotus obliquus is a kind of mushroom which grows birch sap as a nutrient source. Beta glucan, which acts as a superoxide dismutase, It contains several hundreds of enzymes to remove active oxygen in the body. It contains immunity-enhancing ingredients. It reduces fat and blood sugar in cholesterol, strengthens immunity, prevents adult disease, It removes the active oxygen that is formed and alkalizes it by the decrease of the acidity in the body and the cleansing of the blood flow, and strengthens the soft cells, thereby increasing the healing power of the human body.
한편, 엉겅퀴(Cirsium japonicum)는 국화과에 속하는 여러해살이 풀로써 경혈, 지혈, 소종의 효능이 알려져 있으며, 간장보호작용과 알코올 유도지질 산화의 예방 및 알코올성 간경화 등에 대한 보호효과가 있다고 보고된 바 있다.On the other hand, thistle (Cirsium japonicum ) is a perennial herb that belongs to the family Asteraceae. Its efficacy has been well known, and it has been reported that it protects against hepatoprotective action, prevention of alcohol induced lipid oxidation, and alcoholic cirrhosis.
한편, 율피는 밤(Castanea crenata)의 열매의 속껍질로서, 피부 주름 개선 효과가 뛰어나고, 위를 보호하며, 인삼의 부작용에 대해 해독 작용을 하는 것으로 알려져 있다.On the other hand, is yulpi night (Castanea crenata ), it is known that it has excellent wrinkle improving effect on the skin, protects the stomach, and detoxifies against side effects of ginseng.
한편, 헛개나무(Hovenia dulcis Thunb)는 갈매나무과의 낙엽활엽교목으로 경기, 강원 이남의 표고 50~800 m에 분포하고 있으며 호깨나무, 허리깨나무, 지구(枳俱), 백석목(白石木), 목밀(木蜜), 현포리(玄圃梨) 등으로도 불린다. 호베니아(Hovenia)속 나무 열매는 본초학이나 식물도설에서 주독해독, 정혈, 이뇨, 갈증해소, 해독작용을 한다는 보고가 있다. 그리고 헛개나무의 잎, 줄기 및 열매로 만든 차가 주독(酒毒) 제거 및 간 기능 보호에 효능이 뛰어난 것으로 전해지고 있다.On the other hand, Hovenia dulcis Thunb is a deciduous broad-leaved arboreous tree, distributed at 50-800 m above sea level in Gyeonggi-do, Gyeongsangnam-do. It is distributed in the order of hippopotamus, backbone, earth, It is also known as wood grain, cypher pear. There is a report that Hovenia natto has toxin decontamination, hematocrit, diuretic, thirst relief and detoxification in herbal medicine and phytomedicine. It is said that tea made from leaf, stem, and fruit of hinoki tree has excellent efficacy in the elimination of alcohol poisoning and protection of liver function.
한편, 예전부터 음주로 인한 숙취 또는 알코올의 독성을 제거하기 위한 숙취해소용 조성물에 대한 연구가 활발하게 진행되고 있으며, 천연원료, 한약재료 또는 인공제제를 함유하는 다양한 숙취해소용 조성물이 개발되고 있다. 하지만, 종래에 개발된 숙취 해소용 조성물들은 아직까지 만족할 만한 효과를 나타내지 못하는 실정이다.
On the other hand, there have been many active researches on hangover detoxification compositions for removing hangover or toxicity of alcohol due to drinking, and a variety of hangover detoxification compositions containing natural raw materials, herbal medicine materials or artificial preparations have been developed . However, conventionally developed compositions for relieving hangover have not yet exhibited satisfactory effects.
본 발명은 천연재료로 이루어져 인체 안정성이 확보된 숙취해소용 식품조성물을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a food composition for hangover breaks which is made of a natural material and has a stable human body.
또한, 본 발명은 신체의 저항력을 증진시키고, 음주 후의 부작용을 매우 효과적으로 억제시키는 숙취해소용 식품조성물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a food composition useful as a hangover remedy which improves the resistance of the body and suppresses side effects after drinking very effectively.
또한, 본 발명은 손상된 간기능을 회복시키고 알코올 중독 및 알코올 의존성을 개선 또는 치료하는데 효과적인 숙취해소용 식품조성물을 제공하는 것을 목적으로 한다.
It is also an object of the present invention to provide a food composition for hangover which is effective for restoring damaged liver function and for alleviating or treating alcohol dependence and alcohol dependence.
상기 목적을 달성하기 위하여, 본 발명의 숙취해소용 식품조성물은 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물, 율피 분말 및 헛개나무 열매 추출물을 포함하는 것을 특징으로 한다.In order to attain the above object, the food composition for hangover of the present invention is characterized by including grape seed extract, chaga mushroom extract, thistle extract, jellyfish powder and hornoya fruit extract.
이하에서는 본 발명에서 사용되는 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물, 율피 분말, 헛개나무 열매 추출물 및 이를 유효성분으로 함유하는 숙취해소용 식품조성물에 대하여 자세히 설명하겠다.Hereinafter, the grape seed extract, chaga mushroom extract, thistle extract, horsetail powder, Hovenia dulcis extract and food composition containing the horsetail used as an active ingredient thereof will be described in detail.
본 발명에 있어서, 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물 또는 헛개나무 열매 추출물을 수득하는 방법으로는, 본 발명이 속하는 기술 분야에서 통상적으로 사용되는 다양한 추출 방법을 이용할 수 있으며, 예를 들면, 물, 메탄올, 에탄올, 프로판올, 부탄올, 글리세롤, 프로필렌글리콜, 1,3-부틸렌글리콜 등의 용매를 각각 단독으로 또는 이들을 2종 이상 혼합한 용매를 추출 용매로 이용할 수 있다. 바람직하게는 40~80% 에탄올 수용액을 이용할 수 있다.In the present invention, a variety of extraction methods commonly used in the technical field of the present invention can be used as a method for obtaining grape seed extract, chaga mushroom extract, thistle extract or Hovenia dulici extract. For example, , A solvent in which methanol, ethanol, propanol, butanol, glycerol, propylene glycol, 1,3-butylene glycol and the like are used alone or as a mixture of two or more thereof may be used as an extraction solvent. Preferably, a 40 to 80% aqueous solution of ethanol can be used.
또한, 본 발명의 추출물은 상술한 추출 용매에 의한 추출물뿐만 아니라, 통상적인 정제 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외여과막을 이용한 분리, 다양한 크로마토그래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 추출물에 포함되는 것이다.In addition, the extract of the present invention includes not only the extract obtained by the above-mentioned extraction solvent, but also an extract obtained through a conventional purification process. For example, by separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatographies (made for separation by size, charge, hydrophobicity or affinity), and the like, Fractions are also included in the extract of the present invention.
또한, 본 발명의 추출물에는 천연물로부터 유용성분을 추출하기 위한 방법으로 널리 이용되어 지고 있는 아임계 및 초임계 추출방법을 통하여 얻어진 추출물도 포함된다. 이들 추출법은 일반적인 추출방법보다 추출 속도가 빠르고, 추출 용매로 환경에 무해한 물질(일 예로서, 초임계 이산화탄소)을 사용하기 때문에 환경에 무해한 장점이 있다.The extract of the present invention also includes extracts obtained through subcritical and supercritical extraction methods widely used as methods for extracting useful components from natural products. These extraction methods have advantages in that they are faster in extraction speed than general extraction methods and harmless to the environment because they use substances (for example, supercritical carbon dioxide) which are harmless to the environment as extraction solvents.
또한, 본 발명에 있어서, 추출의 재료가 되는 포도씨, 차가버섯, 엉겅퀴 또는 헛개나무 열매는 이를 건조하여 사용하거나 또는 그대로 사용할 수 있다. 바람직하게는 건조하여 사용할 수 있는데, 건조법으로는 자연 건조 또는 열풍 건조법 등을 이용할 수 있다. 또한, 상기 포도씨, 차가버섯, 엉겅퀴 또는 헛개나무 열매는 이를 분쇄하여 사용할 수도 있는데, 상기 재료들을 분쇄하여 사용하면 추출을 용이하게 할 수 있다는 이점이 있다. In the present invention, the grape seed, the carrot mushroom, the thistle or the Houttuynia chinensis which is the material of the extraction can be dried or used as it is. The drying method may be dry drying or hot air drying. In addition, grape seed, chaga mushroom, thistle or Hovenia dulcis can be used by pulverizing them. If the materials are pulverized, they can be easily extracted.
또한, 본 발명의 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물 또는 헛개나무 열매 추출물은 액체 상태로 사용할 수 있지만, 감압 증류, 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조하여 사용하는 것이 바람직하다. In addition, the grape seed extract, chaga mushroom extract, thistle extract or Hovenia dulcis extract of the present invention can be used in a liquid state, but it is preferable to prepare the grape seed extract in powder form by an additional process such as vacuum distillation, freeze drying or spray drying Do.
또한, 본 발명의 율피 분말은 율피를 자연 건조 또는 열풍 건조법 등을 이용하여 건조한 후, 분쇄하여 제조할 수 있다.In addition, the pulp powder of the present invention can be prepared by drying the pulp by natural drying or hot-air drying, and then pulverizing the pulp.
한편, 본 발명은 상기와 같이 제조된 포도씨 추출물, 차가버섯 추출물, 엉겅퀴 추출물, 율피 분말 및 헛개나무 열매 추출물을 이용하여 숙취해소에 탁월한 효과를 나타내는 숙취해소용 식품조성물을 제조할 수 있다. 바람직하게는 본 발명의 숙취해소용 식품조성물은 포도씨 추출물 42~48중량%, 차가버섯 추출물 23~27중량%, 엉겅퀴 추출물 12~17중량%, 율피 분말 3~8중량% 및 헛개나무 열매 추출물 2~6중량%를 포함하는 것이 바람직한데, 상기 범위를 만족하는 경우, 알코올 분해능이 매우 탁월하며 숙취해소에 우수한 효과를 발휘할 수 있다. Meanwhile, the present invention can be used to produce a food composition for hangover marinades, which exhibits an excellent effect in eliminating hangover, by using the grape seed extract, chaga mushroom extract, thistle extract, urnae powder and Hovenia dulcis extract prepared as described above. Preferably, the food composition of the present invention for hangover is composed of 42 to 48% by weight of grape seed extract, 23 to 27% by weight of chaga mushroom extract, 12 to 17% by weight of thistle extract, 3 to 8% by weight of zulberry powder, By weight to 6% by weight. When the above range is satisfied, the alcohol decomposing ability is very excellent, and an excellent effect can be exhibited on hangover resolution.
또한, 본 발명의 숙취해소용 식품조성물은 분말, 과립, 정제, 캡슐, 사탕, 껌 또는 음료 형태의 식품으로 제조될 수 있으며, 숙취해소용 식품의 제조를 위해 기타의 천연 또는 합성 물질 및 첨가물 등을 추가로 포함할 수 있다.
In addition, the food composition of the present invention for hangover can be manufactured as a powder, a granule, a tablet, a capsule, a candy, a gum or a food in the form of a drink, and other natural or synthetic substances and additives May be further included.
본 발명은 천연재료로 이루어져 인체 안정성이 확보된 숙취해소용 식품조성물을 제조할 수 있다.The present invention can produce a food composition for hungry poultry which is made of a natural material and has secured human stability.
또한, 본 발명은 신체의 저항력을 증진시키고, 음주 후의 부작용을 매우 효과적으로 억제시킬 수 있는 숙취해소용 식품조성물을 제조할 수 있다.In addition, the present invention can prepare a food composition for hangover break which can enhance the resistance of the body and can suppress the side effects after drinking very effectively.
또한, 본 발명은 손상된 간기능을 효과적으로 회복시키고, 알코올 중독 및 알코올 의존성을 개선 또는 치료하는데 효과적인 숙취해소용 식품조성물을 제조할 수 있다.
In addition, the present invention can produce a food composition useful in hangover, which effectively restores damaged liver function and is effective in improving or treating alcohol dependence and alcohol dependence.
이하, 본 발명의 내용을 하기 실시예를 들어 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the scope of the present invention is not limited to the following embodiments, and includes modifications of equivalent technical ideas.
제조예 1: 숙취해소용 식품조성물의 제조Production Example 1: Preparation of Food Composition for Hangover
포도씨, 차가버섯, 엉겅퀴 또는 헛개나무 열매를 건조한 후 소정의 크기로 잘게 분쇄하였다. 상기 각각 분쇄된 원료에 70% 에탄올 수용액을 첨가하여 100~150℃에서 3~6시간 교반하며 가열함으로써 추출하였다. 그 다음 여과포를 이용하여 상기 추출물들을 여과한 후, 동결건조하여 원료들의 추출분말을 제조하였다. 또한, 율피는 건조시켜 미세하게 분쇄하여 율피 분말을 제조하였다. Grape seed, chaga mushroom, thistle or Hovenia dulcis were dried and finely ground to a predetermined size. A 70% aqueous ethanol solution was added to each of the pulverized raw materials, and the mixture was extracted by heating at 100 to 150 ° C for 3 to 6 hours with stirring. Then, the extracts were filtered using a filter cloth and then lyophilized to prepare an extract powder of raw materials. In addition, the hull was dried and finely pulverized to prepare a hull.
상기 수득된 포도씨 추출분말 42~48중량%, 차가버섯 추출분말 23~27중량%, 엉겅퀴 추출분말 12~17중량%, 율피 분말 3~8중량% 및 헛개나무 열매 추출분말 2~6중량%를 혼합하여 숙취해소용 식품조성물을 제조하였다.
The resulting grape seed extract powder (42 to 48 wt.%), Chrysanthemum extract powder (23 to 27 wt.%), Thistle extract powder (12 to 17 wt.%), Hulli powder (3 to 8 wt.%) And mixed to give a hangover food composition.
비교예Comparative Example 1 내지 5: 숙취해소용 조성물 제조 1 to 5: preparation of composition for sputum horn
본 비교예에서는 상기 제조예 1의 숙취해소용 식품조성물의 조성성분 중 성분을 하나씩 제외하여 비교예 1 내지 5를 제조하였다(표 1 참조).In this Comparative Example, the components in the composition components of the food composition for hangover in hunch of Preparation Example 1 were excluded one by one to prepare Comparative Examples 1 to 5 (see Table 1).
비교예Comparative Example 6 내지 10: 숙취해소용 조성물 제조 6 to 10: Preparation of composition for sputum rouge
본 비교예에서는 제조예 1의 숙취해소용 식품조성물의 조성성분비를 달리하여 비교예 6 내지 10을 제조하였다(표 2 참조).In this Comparative Example, Comparative Examples 6 to 10 were prepared by varying the composition ratio of the food composition for hangover breakage of Production Example 1 (see Table 2).
분말Julie
powder
실험예Experimental Example 1: One: ADHADH 와 Wow ALDHALDH 의 활성 측정(Activity measurement of inin vitrovitro ))
본 실험예에서는 상기 제조예 1 및 비교예 1 내지 10에서 제조한 숙취해소용 조성물에 대한 ADH와 ALDH의 활성을 측정하였다.In this Experimental Example, the activities of ADH and ALDH were measured for the composition for hangover hunting prepared in Preparation Example 1 and Comparative Examples 1 to 10.
알코올은 간에서 알코올 탈수소효소(alcohol dehydrogenase; ADH)에 의해 아세트알데하이드로 산화되고, 다시 알데하이드 탈수소효소(aldehyde dehydrogenase; ALDH)에 의해 아세트산과 수소로 분해된 뒤 소변을 통해 배설된다. 숙취 현상을 효과적으로 완화시키기 위해서는 아세트알데하이드의 분해가 빨리 이루어져야 한다.Alcohol is oxidized to acetaldehyde by alcohol dehydrogenase (ADH) in the liver and then decomposed into acetic acid and hydrogen by aldehyde dehydrogenase (ALDH) and excreted through the urine. Decay of acetaldehyde must be done quickly to effectively relieve hangover.
ADH와 ALDH의 활성 측정은 'Blandino의 방법(Bostian. et. al., 1978)'을 변형하여 측정하였으며, 흡광도는 340 nm에서 NADH의 생성속도를 지표로 사용하였다.The activity of ADH and ALDH was measured by modifying 'Blandino's method (Bostian et al., 1978)', and the absorbance was used as an index of the NADH production rate at 340 nm.
측정 결과(표 3참조), 제조예 1의 숙취해소용 식품조성물이 비교예 1 내지 10에 비해 ADH 및 ALDH의 활성 촉진 효과가 우수하다는 것을 확인할 수 있었고, 이로부터 본 발명 조성물의 우수한 숙취해소 효과를 확인할 수 있었다.
From the results of the measurement (see Table 3), it was confirmed that the food composition for hangover resolution of Production Example 1 was superior in the activity of promoting the activity of ADH and ALDH as compared with Comparative Examples 1 to 10, .
실험예 2: 숙취해소용 식품조성물 투여 후 시간 경과에 따른 혈중 알코올 농도Experimental Example 2: Blood alcohol concentration over time after administration of food composition for hangover
본 실험예에서는 생쥐 60마리에 상기 제조예 1 및 비교예 1 내지 10에서 제조된 숙취해소용 조성물을 투여한 후, 시간 경과에 따른 혈중 알코올 농도를 측정하고자 하였다.In this experiment, blood alcohol concentration was measured over time after administration of the composition for hangover treatment prepared in Preparation Example 1 and Comparative Examples 1 to 10 to 60 rats.
생쥐 60마리 중 5마리는 대조군으로 0.6 ㎖의 증류수를 투여하고, 증류수 투여 30분 후에 알코올(알코올 도수, 40%v/v)를 0.3 ㎖ 투여하였다.Five of 60 mice were administered with 0.6 ml of distilled water as a control group and 0.3 ml of alcohol (alcoholic water, 40% v / v) 30 minutes after the administration of distilled water.
한편, 60마리 중 나머지 5마리는 제조예 1를 나머지 50마리는 5마리씩 나누어 비교예 1 내지 10을 각각 0.6 ㎖씩 투여하고 30분 후에 알코올(알코올 도수, 40%v/v)를 0.3 ㎖ 투여하였다. 그 후, 0, 0.5, 1.0, 2.0, 3.0 시간 경과 후에 각 처리군에서 심장으로부터 혈액을 채취하여 알코올 농도를 측정하였다.On the other hand, the remaining 5 out of 60 animals were divided into 5 groups according to Preparation Example 1, and the remaining 50 animals were administered with 0.6 ml of each of Comparative Examples 1 to 10, 0.3 ml of alcohol (alcoholic water, 40% v / v) Respectively. Thereafter, blood was collected from the heart in each treatment group at 0, 0.5, 1.0, 2.0, and 3.0 hours, and the alcohol concentration was measured.
Elapsed time (hours)
측정 결과(표 4 참조), 제조예 1에서 제조된 숙취해소용 식품조성물 투여시 혈중 알코올이 많이 감소하는 것을 확인할 수 있었다. 이로부터 본 발명 조성물의 우수한 숙취해소 효과를 확인할 수 있었다.
As a result of the measurement (see Table 4), it was confirmed that the blood alcohol was significantly reduced upon administration of the food composition for hangover as prepared in Preparation Example 1. From this, it was confirmed that the composition of the present invention had a good hangover resolution effect.
실시예Example 1: One: 제조예Manufacturing example 1의 숙취 1 hangover 해소능Resolvability 조사 Research
본 실시예에서는 상기 제조예 1 및 비교예 1 내지 10에서 제조된 숙취해소용 조성물의 숙취해소 효과를 측정하기 위하여, 건강한 성인남자 60명(25~50세, 음주경력 5~25년)을 피험자로 선정하여 임상실험을 하였다.In this Example, 60 adult healthy men (25 to 50 years old, 5 to 25 years of drinking experience) were divided into two groups according to the number of subjects And clinical trials were conducted.
실험 전ㆍ후에는 24시간 동안 음주를 금지하고, 실험 당일은 공복으로 실험에 참여하게 하였다.Drinking was prohibited for 24 hours before and after the experiment, and on the day of the experiment, the experiment was performed with fasting.
상기 60명 중 5명은 대조군으로 각각 75 ㎖의 증류수를 투여하고, 증류수 투여 30분 후에 '0.5 g/체중 1 kg'의 알코올(알코올 도수, 40%v/v)이 되도록 조제하여 10분 이내에 전량을 마시도록 하였다.Five of the 60 patients were treated with 75 ml of distilled water and 30 minutes after the administration of distilled water, the animals were adjusted to have an alcohol concentration of 0.5 g / kg body weight (alcoholic strength, 40% v / v) .
한편, 60명 중 5명은 제조예 1을 나머지 50명은 5명씩 나누어 비교예 1 내지 10을 각각 75 ㎖씩 마시게 한 후, 30분 동안 가만히 있게 하였다. 이 후, '0.5 g/체중 1 kg'의 알코올(알코올 도수, 40%v/v)이 되도록 조제하여 10분 이내에 전량을 마시도록 하였다.In the meantime, 5 out of 60 patients were divided into Preparation Example 1, and the remaining 50 patients were divided into 5 patients, and each of Comparative Examples 1 to 10 was treated with 75 ml each, followed by allowing to stand still for 30 minutes. After that, it was adjusted to be 0.5 g / 1 kg of alcohol (alcoholic strength, 40% v / v), and the whole amount was drunk within 10 minutes.
이 후, 숙취의 대표증상으로 나타나는 두통, 구토 및 구갈 정도와 안색 여부를 평가하고, 그 결과를 하기 표 5에 나타내었다. 이때, 두통, 구토 및 구갈 정도와 안색 여부는 모두 '5: 전혀 없음, 4: 없음, 3: 보통, 2: 약간 있음, 1: 매우 심함'으로 하여 수행하였으며, 결과는 그 평균값으로 기재하였다.Headache, nausea, vomiting, and palpitation, which are representative symptoms of hangover, were evaluated and the results are shown in Table 5 below. At this time, the headache, vomiting, and degree of visual complexion were both "5: no, 4: none, 3: normal, 2: slightly, 1: very severe".
실시 결과(표 5 참조), 제조예 1에서 제조된 숙취해소용 식품조성물이 평가항목인 두통, 구토, 구갈 및 안색 항목에서 매우 우수한 결과를 나타냈다. 반면, 본 발명의 숙취해소용 식품조성물 중 어느 하나라도 제외되거나, 조성성분비가 달라질 경우 숙취해소 효과가 낮아지는 것을 확인할 수 있었다.
The results of the test (see Table 5) showed that the food composition for hangover hunting prepared in Preparation Example 1 showed excellent results in the evaluation items of headache, vomiting, dryness and color. On the other hand, it was confirmed that when any one of the food compositions for hangover is excluded or the composition ratio is changed, the hangover resolution effect is lowered.
제조예Manufacturing example 2: 숙취해소용 식품의 제조 2: Manufacture of hangover food
본 제조예에서는 하기와 같이 숙취해소용 식품을 제조하였다.In this Production Example, a hangover food was prepared as follows.
(1) 음료 제조(1) beverage manufacturing
구연산 0.25 g, 과당 35 g, 레몬주스 60 g, 제조예 1의 숙취해소용 식품조성물 20mg을 혼합한 후, 통상의 음료 제조방법에 따라 숙취해소용 음료를 제조하였다.0.25 g of citric acid, 35 g of fructose, 60 g of lemon juice, and 20 mg of the food composition for hangover breakage in Production Example 1 were mixed, and a small-sized beverage was prepared by hanging in accordance with a usual beverage preparation method.
(2) 츄임껌 제조(2) Chewing gum manufacturing
껌 베이스 26.1중량%, 설탕 70.9중량%, 향료 1중량% 및 물 2중량%를 배합한 후, 제조예 1의 숙취해소용 식품조성물 20mg을 첨가하여 통상의 츄잉껌 제조방법에 따라 숙취해소용 츄잉껌을 제조하였다.26.1% by weight of a chewing gum, 70.9% by weight of sugar, 1% by weight of a flavor and 2% by weight of water were mixed and 20 mg of a food composition for hangover was added to prepare a typical chewing gum. .
(3)캔디 제조(3) Candy manufacturing
설탕 63중량%, 물엿 36.9중량%, 및 향료 0.1중량%를 배합한 후, 제조예 1의 숙취해소용 식품조성물 20mg을 첨가하여 통상의 캔디 제조방법에 따라 숙취해소용 캔디를 제조하였다.
After mixing with 63% by weight of sugar, 36.9% by weight of starch syrup, and 0.1% by weight of fragrance, 20 mg of the food composition for hangover preparation of Production Example 1 was added and hanged according to a conventional candy manufacturing method to prepare small candies.
Claims (4)
Grape seed extract, chaga mushroom extract, thistle extract, juli powder, and Hovenia dulcis extract.
상기 조성물은,
포도씨 추출물 42~48중량%, 차가버섯 추출물 23~27중량%, 엉겅퀴 추출물 12~17중량%, 율피 분말 3~8중량% 및 헛개나무 열매 추출물 2~6중량%를 포함하는 것을 특징으로 하는 숙취해소용 식품조성물.
The method according to claim 1,
The composition may comprise,
Characterized in that it comprises 42 to 48% by weight of grape seed extract, 23 to 27% by weight of chaga mushroom extract, 12 to 17% by weight of thistle extract, 3 to 8% by weight of horsetail powder and 2 to 6% by weight of horsetail fruit extract (Canceled).
A hangover drinking drink containing the food composition of claim 1 or 2.
A chewable chewing gum comprising the food composition for hangover of claim 1 or 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120040947A KR101461165B1 (en) | 2012-04-19 | 2012-04-19 | Hangover curing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120040947A KR101461165B1 (en) | 2012-04-19 | 2012-04-19 | Hangover curing agent |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130118058A KR20130118058A (en) | 2013-10-29 |
KR101461165B1 true KR101461165B1 (en) | 2014-11-13 |
Family
ID=49636550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120040947A KR101461165B1 (en) | 2012-04-19 | 2012-04-19 | Hangover curing agent |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101461165B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101953441B1 (en) * | 2016-11-07 | 2019-02-28 | 김대호 | Composition for hangover annul material based on oriental medicine material, manufacturing method for pill type hangover annul material using the same, and pill type hangover annul material manufactured by the same |
WO2019059549A2 (en) * | 2017-09-19 | 2019-03-28 | 주식회사 큐젠바이오텍 | COMPOSITION FOR RELIEVING HANGOVER OR COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING ALCOHOLIC LIVER DISEASE, COMPRISING β-GLUCAN AS ACTIVE INGREDIENT |
KR102118731B1 (en) | 2017-09-19 | 2020-06-03 | (주)큐젠바이오텍 | Composition comprising betaglucan as an effective ingredient for relieving hangover or preventing, improving or treating alcoholic liver disease |
KR102011673B1 (en) * | 2019-05-10 | 2019-08-19 | 박은화 | Hangover beverage composition |
KR102434150B1 (en) * | 2020-11-25 | 2022-08-19 | 주식회사 네이처센스 | Compositions for inner beauty containing cirsium japonicum extract as effective component |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070101443A (en) * | 2006-04-10 | 2007-10-17 | 주식회사 당바이오텍 | Composition for removing hangover comprising herbal mixture extract |
KR20100088007A (en) * | 2009-01-29 | 2010-08-06 | 한국생명공학연구원 | A composition for preventing or treating of fatty liver comprising an extract of chestnut inner shell |
KR20100119150A (en) * | 2009-04-30 | 2010-11-09 | 주식회사 진로 | Composition for alleviating a hangover comprising an extract of chestnut(castanea crenata) inner skin |
KR20110033644A (en) * | 2009-09-25 | 2011-03-31 | 황대규 | Composition for curing hangover and method manufacturing thereof |
-
2012
- 2012-04-19 KR KR1020120040947A patent/KR101461165B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070101443A (en) * | 2006-04-10 | 2007-10-17 | 주식회사 당바이오텍 | Composition for removing hangover comprising herbal mixture extract |
KR20100088007A (en) * | 2009-01-29 | 2010-08-06 | 한국생명공학연구원 | A composition for preventing or treating of fatty liver comprising an extract of chestnut inner shell |
KR20100119150A (en) * | 2009-04-30 | 2010-11-09 | 주식회사 진로 | Composition for alleviating a hangover comprising an extract of chestnut(castanea crenata) inner skin |
KR20110033644A (en) * | 2009-09-25 | 2011-03-31 | 황대규 | Composition for curing hangover and method manufacturing thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20130118058A (en) | 2013-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102136052B1 (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
EP2003988B1 (en) | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
KR101461165B1 (en) | Hangover curing agent | |
KR100552398B1 (en) | An alcohol detoxification beverage comprising extract of horse bean | |
US20100080821A1 (en) | Energy Compositions | |
KR101324431B1 (en) | Composition effective for removing hangover | |
KR101093998B1 (en) | Functional composition for the prevention of hangover and improving liver function | |
KR101665584B1 (en) | Composition for eliminating hangover | |
KR101588378B1 (en) | Method for manufacturing hangover curing agent and hangover curing agent manufactured by the same | |
KR101394358B1 (en) | Health composition relieving alcohol hangover | |
KR101045279B1 (en) | Composition of functional food with weight loss effect | |
KR102127411B1 (en) | Composition comprising natural complex extract for protecting liver and relieving hangover | |
KR101897005B1 (en) | Composition for Relieving Hangover Using Ginsenoside Compound K | |
CN114631632B (en) | Rosa roxburghii composition for protecting liver and dispelling effects of alcohol, and preparation and application thereof | |
KR102428520B1 (en) | Manufacturing method of Liquor using Red Ginseng Concentrate, Angelica Extract, Chlorella and Perilla Frutescens Extract | |
WO2000064286A1 (en) | Method of extracting from hovenia dulcis thunb, using method thereof and food containing extract | |
KR102136053B1 (en) | Composition for Removing Hangover Comprising Herb Extract and Beverage Thereof | |
KR20050100890A (en) | Composition comprising the extract of acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome | |
KR20100065805A (en) | Alcohol detoxification composition | |
Airaodion et al. | Chemical Composition and Nutraceutical Potential of Velvet Tamarind (Dialium guineense wild) Fruit Pulp | |
KR102269936B1 (en) | A beverage composition for relieving hangover and preparing method the same | |
KR20200142768A (en) | Composition for hangover cure conprising oriental herbal extract | |
KR102454995B1 (en) | Composition for improving hangover and method for manufacturing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20181024 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20191024 Year of fee payment: 6 |